Clinical Trial Update: Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of naloxone hydrochloride for relief of pruritus in patients with cutaneous T-cell lymphoma (Mycosis Fungoides and Sézary Syndrome) has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

Sponsor: Elorac, Inc. | Conditions: Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous | Phase 3 | Status: TERMINATED